Standard
Plasma YKL-40 and total and disease-specific mortality in the general population. / Johansen, Julia S; Bojesen, Stig E; Tybjaerg-Hansen, Anne; Mylin, Anne K; Price, Paul A; Nordestgaard, Børge G.
I:
Clinical Chemistry, Bind 56, Nr. 10, 01.10.2010, s. 1580-91.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Johansen, JS, Bojesen, SE, Tybjaerg-Hansen, A, Mylin, AK, Price, PA
& Nordestgaard, BG 2010, '
Plasma YKL-40 and total and disease-specific mortality in the general population',
Clinical Chemistry, bind 56, nr. 10, s. 1580-91.
https://doi.org/10.1373/clinchem.2010.146530
APA
Johansen, J. S., Bojesen, S. E., Tybjaerg-Hansen, A., Mylin, A. K., Price, P. A.
, & Nordestgaard, B. G. (2010).
Plasma YKL-40 and total and disease-specific mortality in the general population.
Clinical Chemistry,
56(10), 1580-91.
https://doi.org/10.1373/clinchem.2010.146530
Vancouver
Johansen JS, Bojesen SE, Tybjaerg-Hansen A, Mylin AK, Price PA
, Nordestgaard BG.
Plasma YKL-40 and total and disease-specific mortality in the general population.
Clinical Chemistry. 2010 okt. 1;56(10):1580-91.
https://doi.org/10.1373/clinchem.2010.146530
Author
Johansen, Julia S ; Bojesen, Stig E ; Tybjaerg-Hansen, Anne ; Mylin, Anne K ; Price, Paul A ; Nordestgaard, Børge G. / Plasma YKL-40 and total and disease-specific mortality in the general population. I: Clinical Chemistry. 2010 ; Bind 56, Nr. 10. s. 1580-91.
Bibtex
@article{e9d3de1a284c4757b968a13d819b4683,
title = "Plasma YKL-40 and total and disease-specific mortality in the general population",
abstract = "Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.",
author = "Johansen, {Julia S} and Bojesen, {Stig E} and Anne Tybjaerg-Hansen and Mylin, {Anne K} and Price, {Paul A} and Nordestgaard, {B{\o}rge G}",
year = "2010",
month = oct,
day = "1",
doi = "http://dx.doi.org/10.1373/clinchem.2010.146530",
language = "English",
volume = "56",
pages = "1580--91",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry, Inc.",
number = "10",
}
RIS
TY - JOUR
T1 - Plasma YKL-40 and total and disease-specific mortality in the general population
AU - Johansen, Julia S
AU - Bojesen, Stig E
AU - Tybjaerg-Hansen, Anne
AU - Mylin, Anne K
AU - Price, Paul A
AU - Nordestgaard, Børge G
PY - 2010/10/1
Y1 - 2010/10/1
N2 - Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.
AB - Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.
U2 - http://dx.doi.org/10.1373/clinchem.2010.146530
DO - http://dx.doi.org/10.1373/clinchem.2010.146530
M3 - Journal article
VL - 56
SP - 1580
EP - 1591
JO - Clinical Chemistry
JF - Clinical Chemistry
SN - 0009-9147
IS - 10
ER -
